Danil Blinov is currently a Partner Lead for the Midsize Europe Cluster, leveraging over 20 years of diverse experience in the pharmaceutical industry. Their journey spans roles from Medical Representative to Country Manager, with significant expertise in both emerging markets and Western European pharma. Danil has led innovative healthcare approaches, focusing on real-world data and patient outcomes, particularly in their last five years leading the Inflammation and Immunology Business at Pfizer in the Netherlands. Danil holds multiple master's degrees in Sociology and Economics from institutions including The University of Lancaster and Novosibirsk State University.
This person is not in any teams
This person is not in any offices